Kit for increasing Th1 cells
AssigneeImmunovative Therapies Ltd.
InventorMichael Har-Noy
Life of this patent
Estimating the term…
Abstract
The present invention includes vaccine compositions and methods for using these vaccine compositions in active immunotherapy. The vaccine compositions include allogeneic activated Th1 memory cells. The compositions can also include one or more disease-related antigens. The methods include administering the vaccine compositions to provide a Th1 footprint in normal individuals or patients susceptible to disease or having minimal residual disease.
Claims8
A kit for an individual against a tumor or a pathogen comprising a priming composition and an activating composition, wherein the priming and the activating composition both comprise allogeneic activated Th1 memory cells from the same source and wherein the priming composition upon administration increases the number of Th1 cells in circulation in a patient.
Dependencies are inferred from the claim text.